雅本化学(300261) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was approximately ¥408.81 million, representing a decrease of 16.29% year-on-year[8]. - Net profit attributable to shareholders of the listed company was approximately ¥43.68 million, a decline of 57.92% compared to the same period last year[8]. - Basic earnings per share for the reporting period were ¥0.0453, a decrease of 57.95% compared to the previous year[8]. - The company's operating cash flow for the period was CNY 60.80 million, a decrease of CNY 127.24 million or 67.67% compared to the same period last year, attributed to increased cash payments for goods and services[21]. - The company's financial expenses for the period were CNY 253.92 million, an increase of CNY 279.72 million or 1084.35% compared to the same period last year, primarily due to exchange rate fluctuations and interest on loans[21]. - The company's income tax expense for the period was CNY 5.18 million, a decrease of CNY 15.63 million or 75.11% compared to the same period last year, due to production and sales impacts from the shutdown of a subsidiary[21]. - The company's total operating revenue for Q3 2019 was CNY 408,814,277.11, a decrease of 1.1% compared to CNY 415,034,545.06 in the same period last year[45]. - Net profit for Q3 2019 was CNY 48,636,927.91, slightly down from CNY 49,456,450.11 in Q3 2018[47]. - The net profit for the third quarter of 2019 was CNY 63,297,648.91, a decrease of 51.1% compared to CNY 129,639,451.11 in the same period last year[57]. - The total profit for the quarter was CNY 68,476,728.80, down 54.4% from CNY 150,444,423.64 year-over-year[57]. Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥3.45 billion, a decrease of 5.13% compared to the end of the previous year[8]. - Net assets attributable to shareholders of the listed company were approximately ¥1.93 billion, down 2.91% from the previous year[8]. - The cash balance at the end of the period was CNY 313.22 million, a decrease of CNY 282.15 million or 47.39% compared to the end of the previous year, primarily due to cash outflows from investment activities of CNY 117.92 million and financing activities of CNY 76.70 million[21]. - The balance of prepaid accounts at the end of the period was CNY 108.68 million, an increase of CNY 57.24 million or 111.28% compared to the end of the previous year, mainly due to advance inventory preparations for the fourth quarter[21]. - The company's long-term borrowings at the end of the period were CNY 61.00 million, a decrease of CNY 79.25 million or 56.51% compared to the end of the previous year, due to loan repayments[21]. - Total liabilities decreased to CNY 1,416,561,111.98 from CNY 1,556,178,255.79[35]. - The company's total assets decreased to CNY 2,176,201,141.77 from CNY 2,356,763,954.94 in the previous year[44]. - Total liabilities decreased to CNY 536,115,417.82 from CNY 588,105,112.47 year-on-year[42]. - The company's total assets were reported at CNY 3,447,898,174.17, down from CNY 3,634,461,471.46[34]. - The equity attributable to shareholders decreased to CNY 1,928,800,273.77 from CNY 1,986,526,109.98[37]. Cash Flow - The net cash flow from operating activities was not disclosed, but it decreased by 67.67% compared to the previous year[8]. - Cash inflow from financing activities was CNY 671,860,211.86, an increase from CNY 595,900,382.40 in the previous period, reflecting a growth of approximately 12.5%[66]. - Cash outflow from investing activities totaled CNY 328,658,769.11, compared to CNY 460,797,498.67 in the previous period, indicating a decrease of approximately 28.7%[66]. - Net cash flow from financing activities was negative CNY 76,696,325.65, worsening from negative CNY 64,567,847.68 in the previous period[67]. - The company reported a cash and cash equivalents balance of CNY 236,234,993.28 at the end of the period, down from CNY 613,513,935.08[67]. - The company reported a net cash increase from operating activities of CNY 147,247,318.66, significantly higher than CNY 18,169,455.54 in the previous period[68]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,454[13]. - The company announced a cash dividend of CNY 0.5 per 10 shares for the fiscal year 2018, approved on May 10, 2019, and distributed on June 20, 2019[27]. - For the first half of 2019, the company proposed a similar cash dividend of CNY 0.5 per 10 shares, approved on September 10, 2019, and distributed on September 20, 2019[27]. Research and Development - Research and development expenses for Q3 2019 were CNY 23,082,378.63, up from CNY 19,648,630.73 in the same period last year[45]. - Research and development expenses increased to ¥2,552,061.38 from ¥1,972,298.87, reflecting a focus on innovation[53]. - Research and development expenses were CNY 6,612,276.15, a decrease of 22.8% compared to CNY 8,575,808.00 in the previous year[62].